Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Trends Mol Med. 2021 Jan 4;27(5):436–450. doi: 10.1016/j.molmed.2020.12.001

Figure 6: Intranasal Administration of Mucus Penetrating Particles.

Figure 6:

Intranasal drug administration is often used for delivery to the respiratory tract. In several studies, mucus penetrating particles (MPPs), carrying drug or genetic cargo, have been shown to increase coverage in the airways of rodents, as compared to conventional particles (CPs) or free drug.